Armata Pharmaceuticals, Inc.
ARMP
$2.68
$0.2510.29%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -281.34% | 73.90% | 113.10% | 82.41% | 353.34% |
| Total Depreciation and Amortization | 16.19% | 18.93% | 29.69% | 41.63% | 38.16% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 156.94% | -101.45% | -211.06% | -113.04% | -225.84% |
| Change in Net Operating Assets | -201.97% | 29.26% | 113.46% | -1,116.30% | 77.71% |
| Cash from Operations | 29.14% | 28.38% | 2.21% | 8.51% | 15.61% |
| Capital Expenditure | 89.09% | 60.40% | 103.21% | 90.32% | -515.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 89.09% | 60.40% | 103.22% | 90.32% | -515.32% |
| Total Debt Issued | -- | -71.34% | -- | -100.00% | 100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | 100.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | -71.41% | 100.00% | -100.25% | 123.91% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 35.75% | -90.43% | 25.51% | -179.82% | 9.45% |